Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease
Christopher S. Hourigan(National Heart Lung and Blood Institute), Mitchell E. Horwitz(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Mehdi Hamadani(Medical College of Wisconsin), Mingwei Fei(Medical College of Wisconsin), Hugo F. Fernández(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Brent R. Logan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jack Ghannam(Harvard University), Asad Bashey, Alan Howard(National Marrow Donor Program), Abel Licon, Gege Gui(Johns Hopkins University), Laura W. Dillon(Institute of Cancer Research), Erica D. Warlick(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Sergio Giralt(Memorial Sloan Kettering Cancer Center), Edwin P. Alyea(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Bart L. Scott(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Richard T. Maziarz(Oregon Health & Science University), Marcelo C. Pasquini(Cleveland Clinic), David Porter(University of Pennsylvania), Steven M. Devine(National Marrow Donor Program), Yuesheng Li(National Institutes of Health), H. Joachim Deeg(Fred Hutch Cancer Center)
Cited by 441
Related Papers
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k